CRVSCorvus Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $14.71 (+0.14% today)

Market Cap: $1.23B

P/E (TTM): -75.90

Analyst Upside: 102.8%

Relative Strength (RS%): 42

-45.4% from 52-week high

Back to Scanner

CRVS

NASDAQRS 42Score 34

Corvus Pharmaceuticals, Inc.

HealthcareBiotechnology$1.23B1 setup passing
$14.71
+0.1% ($0.02)
-45.4% from 52W High
P/E (TTM)
-75.90
Fwd P/E
PEG
Analyst Upside
+102.8%
EPS Growth
Gross Margin
0.0%
ROE
-23.3%
D/E
0.02
Div Yield
0.0%
Avg Volume
660.5K

Price Chart

Key Levels

SMA 200
$9.35
SMA 50
$17.64
Price
$14.71
52W High
$26.94
Target
$29.83

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst